Journals / Selçuk Tıp Dergisi / 2008 / Cilt: 24 - Sayı: 2

The hematological sign and complications of cyanotic congenital heart diseases

Siyanotik doğumsal kalp hastalıklarında hematolojik bulgu ve komplikasyonlar

Pages
113–122
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The lack of practical therapeutic guidelines forced us to consolidate our observations on patients with cyanotic congenital heart disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This review sought to determine the relationship between cyanosis and hematological signs and findings.
📊
Key Findings & Data:Decreased arterial oxygen saturation in cyanotic congenital heart disease causes compensatory rise in hemoglobin and haematocrit levels.
💡
Conclusion & Impact:The lack of practical therapeutic guidelines forced us to consolidate our observations on patients with cyanotic congenital heart disease.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Kalp kusuru · doğuştan · Çocuk

Abstract

Aim: This review sought to determine the relationship between cyanosis and hematological signs and findings. Main finding: Patients with cyanotic congenital heart disease are succeptible to develope hematological side effects. Several findings, including polycytemia, thrombocytopenia, factor deficiencies, iron-deficiency anemia and disseminated intravasculary coagulation have been reported. Decreased arterial oxygen saturation in cyanotic congenital heart disease causes compensatory rise in hemoglobin and haematocrit levels. Erythrocytosis is an adaptive response to improve oxygen transport in cyanotic congenital heart disease. However, at highly increased haematocrit levels patients may experience hyperviscosity symptoms. Iron-deficiency in cyanotic congenital heart disease patients is often overlooked due to elevated hemoglobin concentrations. The detection of a hemostatic abnormality and its correction by appropriate therapy are likely to minimize the side effects. Results: Children with cyanotic congenital heart disease are prone to both thrombosis and hemorrhage. Hematological management of cyanotic congenital heart disease has received little attention. The lack of practical therapeutic guidelines forced us to consolidate our observations on patients with cyanotic congenital heart disease.

Özet

Amaç: Siyanotik doğumsal kalp hastalıklarında hematolojik belirti ve bulgular derlenmiştir. Ana bulgular: Siyanotik doğumsal kalp hastalıklı hastalarda hematolojik yan etkilerin görülme ihtimali yüksektir. Polisitemi, trombositopeni, faktör eksiklikleri, demir eksikliği anemisi ve yaygın damariçi pıhtılaşması gibi birçok bulgu ve belirtiler bildirilmiştir. Siyanotik doğumsal kalp hastalarında azalmış arteriyel oksijen saturasyonu hemoglobin ve hematokrit değerlerinde kompanzatuar artışlara yol açar. Eritrositoz siyanotik doğumsal kalp hastalarında yeterli oksijenizasyonu sağlamak için ortaya çıkan bir cevaptır. Ancak hematokrit değerleri çok artmış hastalarda hiperviskozite bulguları ortaya çıkabilir. Siyanotik doğumsal kalp hastalıklı çocuklarda demir eksikliği hemoglobin değerleri yüksek olduğu için gözden kaçabilir. Hemostatik anormalliklerin zamanında tespiti ve uygun tedavi yaklaşımları ile yan etkiler azaltılabilir. Sonuç: Siyanotik doğumsal kalp hastalığı olan çocuklar hem tromboz hem de kanamaya eğilimlidir. Bu çocukların hematolojik açıdan takipleri az ilgi çekmektedir. Bu hastalara yönelik olarak pratik tedavi yaklaşımları geliştirilmediği için siyanotik doğumsal kalp hastalıklı çocuklara yönelik çalışmalar yapılmalıdır.

🔖

Cite This Article

BAYSAL, T., KARAASLAN, S. (2008). The hematological sign and complications of cyanotic congenital heart diseases. Selçuk Tıp Dergisi, Cilt: 24 - Sayı: 2, 113–122. https://ajindex.com/articles/319307

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Park MK, Pathophysiology of cyanotic congenital heart defects. In: Park MK; ed. Pediatric cardiology for practitioners. 4th ed. St. Louis: Mosby; 2002:313-6
  2. Corrigan JJ. Hematologic aspects of cardiology. In: Allen DH, Gutgesell HP, Clark EB, Driscoll DJ, eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents. Philadelphia: Lippincott Williams & Wilkins USA; 2001: 1446-57
  3. Therrien J, Webb GD. Medical management of cyanotic congenital heart disease In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia: W B Saunders Company USA; 2001: 1617-19
  4. Gidding SS, Stockman JA. Erythropoietin in cyanotic heart disease. Am Heart J 1988; 116: 128-32
  5. Ryan T, Harrison JK. Congenital heart disease in the adult. In: DuPont HL, Gardner LB, Griffin JW, Harris ED, Hazzard WR, King TE, Loriaux DL, Nabel EG, Todd RF, Traber PG, eds. Kelley’s Textbook of Internal Medicine. Philadelphia: Lippincott Williams &Wilkins USA; 2000: 521-40
  6. Marelli AJ, Moodie DS. Adult congenital heart disease. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. Philadelphia: Lippincott Williams & Wilkins USA; 1998: 769-816
  7. Stockman JA. III, Ezekowitz R AB. Hematologic manifestations of systemic disease. In: Nathan DG, Orkin SH, eds. Nathan and Oski’s Hematology of Infancy and Childhood. Philadelphia: W. B. Saunders company USA; 1998: 1841-4
  8. Marelli AJ. Congenital heart disease in adults. In: Goldman L, Bennett JC, eds. Cecil Textbook of Medicine Philadelphia: W.B. Saunders Company USA; 2000: 279-91
  9. Perloff JK, Marelli AJ, Miner PD. Risk of stroke in adults with cyanotic congenital heart disease. Circulation 1993; 87: 1954-9
  10. Gaiha M, Sethi HP, Sudha R, Arora R, Acharya NR. A clinico-hematological study of iron deficiency anemia and its correlation with hyperviscosity symptoms in cyanotic congenital heart disease. Indian Heart J 1993; 45: 53-5
  11. Swan L, Birnie DH, Hillis WS. The haematological management of patients with cyanotic congenital heart disease. A time for consensus ? Eur Heart J 1997; 18: 1973-6
  12. Maurer HM, McCue CM, Robertson LW, Haggins JC. Correction of platelet dysfunction and bleeding in cyanotic congenital heart disease by simple red cell volume reduction. Am J Cardiol 1975; 35:831-5
  13. Dreyer ZE, Mahoney DH, McClain KL, Poplack DG. Hematologic issues of importance for the pediatric cardiologist. In: Garson A, Bricker JT, Fisher DJ, Neish SR, eds. The Science and Pra